Suchergebnisse - "Mandke, Charuta"

PubPharm (8)

1

Perturbations of immune landscape in COVID-19 associated mucormycosis

enthalten in: Mycoses | 2023

von Desai, N. | Pradhan, V. | Chougule, D. | +15

2

Clinico-Epidemiologic Characteristics of Patients Reported in the Mycotic Infections in COVID-19 Registry

enthalten in: The American journal of tropical medicine and hygiene | 2023

von Maini, R. | Saini, N. | Bhavana, K. | +19

3

Perturbations of immune landscape in COVID‐19 associated mucormycosis

enthalten in: Mycoses | 2023

von Desai, N. | Pradhan, V. | Chougule, D. | +15

4

Factors Associated with Mortality in Coronavirus-Associated Mucormycosis : Results from Mycotic Infections in COVID-19 (MUNCO) Online Registry

enthalten in: Journal of clinical medicine | 2022

von Arora, S. | Narayanan, S. | Fazzari, M. | +21

5

Quantitative B and T cell abnormalities in four patients presenting with mucormycosis and prior asymptomatic COVID-19 infection

enthalten in: BMJ case reports | 2022

von Mandke, C. | Divekar, R. | Pradhan, V. | +1

6

Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1

enthalten in: Indian journal of ophthalmology | 2021

von Sen, M. | Honavar, S. | Bansal, R. | +99

7

Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021

enthalten in: Emerging infectious diseases | 2021

von Arora, S. | Hemmige, V. | Mandke, C. | +8

8

Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa : a modelling study

enthalten in: The Lancet. Global health | 2019

von Lin, J. | Moran, A. | Bibbins-Domingo, K. | +4

CommentIn: Lancet Glob Health. 2019 Oct;7(10):e1290-e1292. - PMID 31477546

1
[1]